2014 Epilepsy Benchmarks Area III: Improve Treatment Options for Controlling Seizures and Epilepsy-Related Conditions Without Side Effects

doi:10.5698/1535-7511-16.3.192

. 2016 May-Jun;16(3):192-7.

doi: 10.5698/1535-7511-16.3.192.

2014 Epilepsy Benchmarks Area III: Improve Treatment Options for Controlling Seizures and Epilepsy-Related Conditions Without Side Effects

Affiliations

¹ Professor of Neurology and Pediatrics, The Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
² Associate Professor of Neurology, Mayo Systems Electrophysiology Laboratory, Departments of Neurology and Biomedical Engineering, Mayo Clinic, Rochester, MN.
³ Assistant Professor, Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
⁴ Assistant Professor of Neurology, Department of Neurology, Department of Biomedical Engineering, University of Michigan.
⁵ Professor, Department of Neurology, University of Alabama at Birmingham Department of Neurology and UAB Epilepsy Center, Birmingham, AL.
⁶ Profressor of Clinical Neurology, Department of Neurology, University of Miami, Miller School of Medicine, Miami, FL.
⁷ Assistant Professor, Department of Biomedical Engineering, University of Kentucky, Lexington, KY.
⁸ Professor, Center for Neurotherapeutics Discovery and Development and Department of Neurology, UC Davis School of Medicine, Sacramento, CA.
⁹ Associate Professor, Department of Pharmaceutical Sciences, University of Maryland Eastern Shore, Princess Anne, MD.
¹⁰ Associate Professor, Division of Epilepsy and Clinical Neurophysiology, Department of Neurology, Boston Children's Hospital & Harvard Medical School, Boston, MA.
¹¹ Clinical Neurophysiologist and Neurologist, Department of Clinical and Experimental Epilepsy, Institute of Neurology, University College London, London, UK.
¹² Program Director, Channels Synapses and Circuits Cluster, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD.
¹³ Professor and Chair, Department of Pharmacology, Emory University, Atlanta, GA.

PMID: 27330452
PMCID: PMC4913858
DOI: 10.5698/1535-7511-16.3.192

2014 Epilepsy Benchmarks Area III: Improve Treatment Options for Controlling Seizures and Epilepsy-Related Conditions Without Side Effects

Dennis Dlugos et al. Epilepsy Curr. 2016 May-Jun.

. 2016 May-Jun;16(3):192-7.

doi: 10.5698/1535-7511-16.3.192.

Authors

Affiliations

¹ Professor of Neurology and Pediatrics, The Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
² Associate Professor of Neurology, Mayo Systems Electrophysiology Laboratory, Departments of Neurology and Biomedical Engineering, Mayo Clinic, Rochester, MN.
³ Assistant Professor, Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
⁴ Assistant Professor of Neurology, Department of Neurology, Department of Biomedical Engineering, University of Michigan.
⁵ Professor, Department of Neurology, University of Alabama at Birmingham Department of Neurology and UAB Epilepsy Center, Birmingham, AL.
⁶ Profressor of Clinical Neurology, Department of Neurology, University of Miami, Miller School of Medicine, Miami, FL.
⁷ Assistant Professor, Department of Biomedical Engineering, University of Kentucky, Lexington, KY.
⁸ Professor, Center for Neurotherapeutics Discovery and Development and Department of Neurology, UC Davis School of Medicine, Sacramento, CA.
⁹ Associate Professor, Department of Pharmaceutical Sciences, University of Maryland Eastern Shore, Princess Anne, MD.
¹⁰ Associate Professor, Division of Epilepsy and Clinical Neurophysiology, Department of Neurology, Boston Children's Hospital & Harvard Medical School, Boston, MA.
¹¹ Clinical Neurophysiologist and Neurologist, Department of Clinical and Experimental Epilepsy, Institute of Neurology, University College London, London, UK.
¹² Program Director, Channels Synapses and Circuits Cluster, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD.
¹³ Professor and Chair, Department of Pharmacology, Emory University, Atlanta, GA.

PMID: 27330452
PMCID: PMC4913858
DOI: 10.5698/1535-7511-16.3.192

No abstract available

PubMed Disclaimer

Cited by

Validated animal models for antiseizure drug (ASD) discovery: Advantages and potential pitfalls in ASD screening.
Barker-Haliski M, Steve White H. Barker-Haliski M, et al. Neuropharmacology. 2020 May 1;167:107750. doi: 10.1016/j.neuropharm.2019.107750. Epub 2019 Aug 27. Neuropharmacology. 2020. PMID: 31469995 Free PMC article. Review.
The 2021 Epilepsy Research Benchmarks-Respecting Core Principles, Reflecting Evolving Community Priorities.
Marsh ED, Whittemore V, Leenders M, Poduri A; American Epilepsy Society Epilepsy Research Benchmark Stewards Committee. Marsh ED, et al. Epilepsy Curr. 2021 Jun 30;21(5):389-393. doi: 10.1177/15357597211023712. eCollection 2021 Oct. Epilepsy Curr. 2021. PMID: 34924844 Free PMC article. No abstract available.
Chemical biomarkers of epileptogenesis and ictogenesis in experimental epilepsy.
Luna-Munguia H, Zestos AG, Gliske SV, Kennedy RT, Stacey WC. Luna-Munguia H, et al. Neurobiol Dis. 2019 Jan;121:177-186. doi: 10.1016/j.nbd.2018.10.005. Epub 2018 Oct 7. Neurobiol Dis. 2019. PMID: 30304705 Free PMC article.
Glucose-6-phosphate dehydrogenase alleviates epileptic seizures by repressing reactive oxygen species production to promote signal transducer and activator of transcription 1-mediated N-methyl-d-aspartic acid receptors inhibition.
Hu L, Liu Y, Yuan Z, Guo H, Duan R, Ke P, Meng Y, Tian X, Xiao F. Hu L, et al. Redox Biol. 2024 Aug;74:103236. doi: 10.1016/j.redox.2024.103236. Epub 2024 Jun 11. Redox Biol. 2024. PMID: 38875958 Free PMC article.
The Benchmarks: Progress and Emerging Priorities in Epilepsy Research.
Poduri A, Whittemore VH. Poduri A, et al. Epilepsy Curr. 2020 Jan-Feb;20(1_suppl):3S-4S. doi: 10.1177/1535759719888646. Epub 2019 Dec 23. Epilepsy Curr. 2020. PMID: 31868039 Free PMC article. No abstract available.

See all "Cited by" articles

References

1. Umpierre AD, Remigio GJ, Dahle EJ, Bradford K, Alex AB, Smith MD, West PJ, White HS, Wilcox KS. Impaired cognitive ability and anxiety-like behavior following acute seizures in the Theiler's virus model of temporal lobe epilepsy. Neurobiol Dis. 2014;64:98–106. - PMC - PubMed
1. Buckingham SC, Ramos TN, Barnum SR. Complement C5-deficient mice are protected from seizures in experimental cerebral malaria. Epilepsia. 2014;55:e139–e142. - PMC - PubMed
1. Eastman CL, Fender JS, Temkin NR, D'Ambrosio R. Optimized methods for epilepsy therapy development using an etiologically realistic model of focal epilepsy in the rat. Exp Neurol. 2015;264:150–162. - PMC - PubMed
1. Rodgers KM, Dudek FE, Barth DS. Progressive, seizure-like, spike-wave discharges are common in both injured and uninjured Sprague-Dawley rats: Implications for the fluid percussion injury model of post-traumatic epilepsy. J Neurosci. 2015;35(24):9194–204. - PMC - PubMed
1. Pearce PS, Friedman D, Lafrancois JJ, Iyengar SS, Fenton AA, Maclusky NJ, Scharfman HE. Spike-wave discharges in adult Sprague-Dawley rats and their implications for animal models of temporal lobe epilepsy. Epilepsy Behav. 2014;32:121–31. doi: 10.1016/j.yebeh.2014.01.004. Epub 2014 Feb 15. - PMC - PubMed

Grants and funding

R01 NS097776/NS/NINDS NIH HHS/United States

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- ClinicalTrials.gov

[1] Umpierre AD, Remigio GJ, Dahle EJ, Bradford K, Alex AB, Smith MD, West PJ, White HS, Wilcox KS. Impaired cognitive ability and anxiety-like behavior following acute seizures in the Theiler's virus model of temporal lobe epilepsy. Neurobiol Dis. 2014;64:98–106. - PMC - PubMed

[2] Umpierre AD, Remigio GJ, Dahle EJ, Bradford K, Alex AB, Smith MD, West PJ, White HS, Wilcox KS. Impaired cognitive ability and anxiety-like behavior following acute seizures in the Theiler's virus model of temporal lobe epilepsy. Neurobiol Dis. 2014;64:98–106. - PMC - PubMed

[3] Buckingham SC, Ramos TN, Barnum SR. Complement C5-deficient mice are protected from seizures in experimental cerebral malaria. Epilepsia. 2014;55:e139–e142. - PMC - PubMed

[4] Buckingham SC, Ramos TN, Barnum SR. Complement C5-deficient mice are protected from seizures in experimental cerebral malaria. Epilepsia. 2014;55:e139–e142. - PMC - PubMed

[5] Eastman CL, Fender JS, Temkin NR, D'Ambrosio R. Optimized methods for epilepsy therapy development using an etiologically realistic model of focal epilepsy in the rat. Exp Neurol. 2015;264:150–162. - PMC - PubMed

[6] Eastman CL, Fender JS, Temkin NR, D'Ambrosio R. Optimized methods for epilepsy therapy development using an etiologically realistic model of focal epilepsy in the rat. Exp Neurol. 2015;264:150–162. - PMC - PubMed

[7] Rodgers KM, Dudek FE, Barth DS. Progressive, seizure-like, spike-wave discharges are common in both injured and uninjured Sprague-Dawley rats: Implications for the fluid percussion injury model of post-traumatic epilepsy. J Neurosci. 2015;35(24):9194–204. - PMC - PubMed

[8] Rodgers KM, Dudek FE, Barth DS. Progressive, seizure-like, spike-wave discharges are common in both injured and uninjured Sprague-Dawley rats: Implications for the fluid percussion injury model of post-traumatic epilepsy. J Neurosci. 2015;35(24):9194–204. - PMC - PubMed

[9] Pearce PS, Friedman D, Lafrancois JJ, Iyengar SS, Fenton AA, Maclusky NJ, Scharfman HE. Spike-wave discharges in adult Sprague-Dawley rats and their implications for animal models of temporal lobe epilepsy. Epilepsy Behav. 2014;32:121–31. doi: 10.1016/j.yebeh.2014.01.004. Epub 2014 Feb 15. - PMC - PubMed

[10] Pearce PS, Friedman D, Lafrancois JJ, Iyengar SS, Fenton AA, Maclusky NJ, Scharfman HE. Spike-wave discharges in adult Sprague-Dawley rats and their implications for animal models of temporal lobe epilepsy. Epilepsy Behav. 2014;32:121–31. doi: 10.1016/j.yebeh.2014.01.004. Epub 2014 Feb 15. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

2014 Epilepsy Benchmarks Area III: Improve Treatment Options for Controlling Seizures and Epilepsy-Related Conditions Without Side Effects

Affiliations

2014 Epilepsy Benchmarks Area III: Improve Treatment Options for Controlling Seizures and Epilepsy-Related Conditions Without Side Effects

Authors

Affiliations

Similar articles

Cited by

References

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical